CLINICAL_TRIALS trial_result · 2012-11-01

Clinical Trial Update: S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas [Phase 2]

Phase 2 trial S0505 evaluated sorafenib in patients with advanced soft tissue sarcoma; the study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2012-11-01